PMID- 24987420 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140702 LR - 20211021 IS - 1687-9627 (Print) IS - 1687-9635 (Electronic) VI - 2014 DP - 2014 TI - Hemophagocytic Syndrome Associated with Immune Reconstitution Inflammatory Syndrome in a Patient with AIDS Related Burkitt's Leukemia/Lymphoma. PG - 308081 LID - 10.1155/2014/308081 [doi] LID - 308081 AB - Highly active antiretroviral therapy (HAART) has markedly decreased human immunodeficiency virus- (HIV-) related mortality and the incidence of opportunistic infections. The dramatic reduction in HIV-1 RNA and increase in CD4 lymphocyte count mean a recovery in immune function. This restoration in immune function may be associated with paradoxical deterioration in subclinical opportunistic infections in some patients, a condition called immune reconstitution inflammatory syndrome (IRIS). IRIS, a "paradoxical" inflammatory response to either previously treated or subclinical infections or noninfectious diseases, can manifest during the restoration phase of immunity hemophagocytic syndrome (HS) which is a very rare complication in patients with acquired immune deficiency syndrome (AIDS). We describe a case of hemophagocytic syndrome associated with IRIS in a patient with AIDS related Burkitt's leukemia/lymphoma (BL). IRIS was probably the cause of hemophagocytosis for our patient. Zoster infection may facilitate to IRIS. With the increasing number of people with HIV infection and the accompanying use of HAART, much more clinical manifestations of IRIS will be experienced especially in patients given high dose chemotherapy, just like in our case. FAU - Kanitez, Metin AU - Kanitez M AD - Department of Medical Oncology, Sisli Education and Research Hospital, Istanbul, Turkey. FAU - Kapmaz, Mahir AU - Kapmaz M AD - Department of Clinical Microbiology and Infectious Disease, Istanbul School of Medicine, Turkey. FAU - Alpay, Nilufer AU - Alpay N AD - Department of Internal Medicine, Istanbul School of Medicine, Turkey. FAU - Selcukbiricik, Fatih AU - Selcukbiricik F AD - Department of Medical Oncology, Sisli Education and Research Hospital, Istanbul, Turkey. FAU - Cagatay, Atahan AU - Cagatay A AD - Department of Clinical Microbiology and Infectious Disease, Istanbul School of Medicine, Turkey. FAU - Diz-Kucukkaya, Reyhan AU - Diz-Kucukkaya R AD - Department of Hematology, Istanbul Bilim University, Turkey. LA - eng PT - Journal Article DEP - 20140527 PL - United States TA - Case Rep Med JT - Case reports in medicine JID - 101512910 PMC - PMC4058513 EDAT- 2014/07/06 06:00 MHDA- 2014/07/06 06:01 PMCR- 2014/05/27 CRDT- 2014/07/03 06:00 PHST- 2014/02/07 00:00 [received] PHST- 2014/04/20 00:00 [accepted] PHST- 2014/07/03 06:00 [entrez] PHST- 2014/07/06 06:00 [pubmed] PHST- 2014/07/06 06:01 [medline] PHST- 2014/05/27 00:00 [pmc-release] AID - 10.1155/2014/308081 [doi] PST - ppublish SO - Case Rep Med. 2014;2014:308081. doi: 10.1155/2014/308081. Epub 2014 May 27.